The Internet Archive, commonly known as Archive.org and IA, is intended to act as a historical archive. In addition to digitally hosting more than 1.4 million books and other documents, Archive.org acts as a historical vault for the internet, preserving cached versions of websites that are no longer accessible to the public.
Read more
Saying remdesivir “has no meaningful effect on mortality or on other important outcomes for patients,” an expert panel at the World Health Organization decided not to recommend the drug as a treatment for COVID-19.
Not all health agencies have been onboard with rejecting the drug, however. The U.S. FDA approved remdesivir in October after a National Institutes of Health study showed that it reduced recovery time of hospitalized patients by four days.
Read more
You may have seen reports about COVID-19 patients who seem unable to fully recover. Some complain of lingering chronic fatigue symptoms. Others struggle with mental health problems. In fact, a study from Oxford University published online November 9, 2020, in The Lancet Psychiatry, found 18.1% of individuals diagnosed with COVID-19 also received a first-time psychiatric diagnosis in the 14 to 90 days afterward.
Read more
As coronavirus testing takes place en masse across the U.S., many are questioning whether the tests are accurate enough to trust, especially in people who are asymptomatic. Positive reverse transcription polymerase chain reaction (RT-PCR) tests have several drawbacks that make mass testing problematic and rife for misleading fearmongering.
Read more
U.S. Right to Know (USRTK), an investigative public health nonprofit group, has filed a lawsuit1 against the National Institutes of Health after the agency failed to respond to the USRTK's July 10, 2020, Freedom of Information Act (FOIA) request. According to the NIH, records were withheld due to them being part of an ongoing legal investigation.
Read more
With more than 180 COVID-19 vaccines currently in development — 53 of them undergoing clinical trials in humans — manufacturers are racing to be the first to reach the market. Pfizer, in a joint venture with Germany-based BioNTech, may have just taken the lead, with an announcement that their mRNA-based vaccine candidate, BNT162b2, was “more than 90% effective” in a Phase 3 trial.
Read more
In this interview, investigative journalist Whitney Webb, who does both independent work and collaborations with The Last American Vagabond, discusses the little-known details of Operation Warp Speed, a joint operation between U.S. Health and Human Services (HHS) and the Department of Defense to produce a fast-tracked COVID-19 vaccine and other therapeutics.
Read more
According to a study that examined how informed consent is given to COVID-19 vaccine trial participants, disclosure forms fail to inform volunteers that the vaccine might make them susceptible to more severe disease if they’re exposed to the virus. The study points out that “COVID-19 vaccines designed to elicit neutralizing antibodies may sensitize vaccine recipients to more severe disease than if they were not vaccinated.”
Read more
From the beginning of the COVID-19 pandemic, the clarion call has been to test, test and test some more. However, right from the start, serious questions arose about the tests being used to diagnose this infection, and questions have only multiplied since then.
Read morePages
for Mercola on COVID-19
Get Local
